How does epoprostenol sodium affect intracellular cAMP and calcium to inhibit platelet aggregation?

Epoprostenol sodium stimulates adenylate cyclase, increasing intracellular cAMP, which stimulates calcium removal and reduces cytoplasmic calcium needed for platelet shape change, aggregation and the release reaction, thereby inhibiting platelet aggregation.